Resumo
Leukocyte and platelet-rich fibrin (L-PRF), an essential source of cytokines and growth factors, has been widely used to regulate the healing process. The quality of the L-PRF obtained is dependent on technical factors and the centrifugation protocol used. Thus, the present study aimed to macro and microscopically evaluate the formation of the L-PRF membrane/clot in two centrifuge models and protocols recommended by manufacturers. Four blood samples from 8 healthy volunteers undergoing rehabilitation surgery with dental implants were used. In group 1 of the Montserrat centrifuge (model 80-2B 15mL) 400g of centrifugal force were used for 10 minutes, 27ºC, and 2700 rpm, while in group 2 of the Intra Spin-Intra-Lock centrifuge (IntraSpin™, Intra-Lock Iberia) 400g of centrifugal force were used for 12 minutes, 27ºC and 2700 rpm. After obtaining 32 L-PRF clots/membranes, the pieces were recorded, measured, and weighed, separating the L-PRF from the supernatant/clot of red blood cells, remaining in the tubes. The specimens were then histologically processed for Hematoxylin/Eosin (H/E) staining and each slide was divided into three called areas: proximal, center, and distal. The presence of leukocytes was analyzed semi-quantitatively in each area. The results revealed no significant macroscopic differences in L-PRF between the two groups. However, the central areas of the L-PRF membranes produced in group 2 showed higher intensity of leukocytes (p=0.012), as well as the presence of concomitant leukocytes in at least 2 of the evaluated areas (p=0.003). In the proximal area, no significant differences were observed between the two groups. The results allow us to postulate that technical protocol factors influence the presence and distribution of leukocytes between the L-PRF membranes, obtained in different centrifuges.
Referências
Del Corso M, Vervelle A, Simonpieri A, et al. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 1: Periodontal and dentoalveolar surgery. Curr Pharm Biotechnol.2012; 13:1207–1230.
Simonpieri A, Del Corso M, Vervelle A, et al. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 2: Bone graft, implant and reconstructive surgery. Curr Pharm Biotechnol.2012;13:1231–1256.
Zumstein MA, Bielecki T, Dohan Ehrenfest DM. The future of platelet concentrates in sports medicine: Platelet-rich plasma, platelet- rich fibrin, and the impact of scaffolds and cells on the long-term delivery of growth factors. Oper Techn Sports Med.2011;19:190–197.
Dohan Ehrenfest, D. M. et al. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane. Platelets. 2017;29(2):171–184.
Dohan Ehrenfest DM, Del Corso M, Diss A, Mouhyi J, Charrier JB. Three-dimensional architecture and cell composition of a Choukroun’s platelet-rich fibrin clot and membrane. J Periodontol. 2010;81:546–555.
Dohan Ehrenfest DM, Peppo GM, Doglioli P, Sammartino G. Slow release of growth factors and thrombospondin-1 in Choukroun’s platelet-rich fibrin (PRF): A gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors. 2009;27:63–69.
Deeb MA. Role of Platelet-Rich Fibrin (PRF) and Platelet-Rich Plasma (PRP) in Oro-Facial Tissue Regeneration: A Narrative Review. Journal of Advanced Oral Research. 2020; 11(1) 5–11.
Dohan ehrenfest, DM., Rasmusson, L., Albrektsson, T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends in Biotechnology. 2009;27(3):158–167.
Choukroun J, Adda F, Schoeffler C, Vervelle A. Une opportunité en paroimplantologie: Le PRF. Implantodontie. 2001;42:55–62.
Dohan ehrenfest DM. et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: Technological concepts and evolution. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology. 2006;101(3).
Dohan ehrenfest DM. How to optimize the preparation of leukocyte- and platelet-rich fibrin (L-PRF, Choukroun’s technique) clots and membranes: Introducing the PRF Box. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology. 2010;110(3):275–278.
Dohan Ehrenfest DM, Del Corso DM. et al. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors and fibrin architecture of a Leukocyte- and Platelet-Rich Fibrin (L-PRF) clot and membrane. Part 3: comparison of the growth factors content and slow re. Poseido. 2014;2(2):155–166.
Miron RJ, Bosshardt DD. OsteoMacs: Key players around bone biomaterials. Biomaterials. 2016;82: 1–19.
Dohan Ehrenfest D. et al. Do the Fibrin Architecture and Leukocyte Content Influence the Growth Factor Release of Platelet Concentrates? An Evidence-based Answer Comparing a Pure Platelet-Rich Plasma (P-PRP) Gel and a Leukocyte- and Platelet-Rich Fibrin (L-PRF). Current Pharmaceutical Biotechnology. 2012;13(7):1145–1152.
Dohan Ehrenfest, D. M. et al. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors and fibrin architecture of a Leukocyte-and Platelet-Rich Fibrin (L-PRF) clot and membrane. Part 1: evaluation of the vibration shocks of 4 models of tab. Poseido Journal. 2014;2(2): 129–39.
Del Corso M, Sammartino G, Dohan Ehrenfest DM. Re: “Clinical Evaluation of a Modified Coronally Advanced Flap Alone or in Combination With a Platelet‐Rich Fibrin Membrane for the Treatment of Adjacent Multiple Gingival Recessions: A 6‐Month Study”. J. Periodontol. 2009;80(11):1694–1697.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Camilla Palmeira Esteves Schleinstein, André Carlos de Freitas, Viviane Palmeira da Silva , Naiadja de Santana Cerqueira, Maria Cristina Teixeira Cangussu, Luciana Maria Pedreira Ramalho